Quest Diagnostics Inc/ US74834L1008 /
2024-11-07 10:10:00 PM | Chg. +1.02 | Volume | Bid2024-11-07 | Ask2024-11-07 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
156.20USD | +0.66% | 525,119 Turnover: 51.81 mill. |
154.33Bid Size: 100 | 158.34Ask Size: 100 | 17.43 bill.USD | 1.82% | 20.58 |
Assets
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 1,145 | 1,288 | 1,453 | 1,627 | 1,707 | ||||||
Intangible Assets | 1,119 | 1,207 | 1,121 | 1,167 | 1,167 | ||||||
Long-Term Investments | 462 | 436 | 482 | 521 | 141 | ||||||
Fixed Assets | 9,197 | 9,613 | 10,353 | 10,968 | 10,870 | ||||||
Inventories | 95 | 99 | 123 | 223 | 208 | ||||||
Accounts Receivable | 924 | 1,012 | 1,063 | 1,520 | 1,438 | ||||||
Cash and Cash Equivalents | 137 | 135 | 1,192 | 1,158 | 872 | ||||||
Current Assets | 1,306 | 1,390 | 2,490 | 3,058 | 2,741 | ||||||
Total Assets | 10,503 | 11,003 | 12,843 | 14,026 | 13,611 |
Liabilities
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 1,021 | 1,021 | 1,041 | 1,633 | 1,600 | ||||||
Long-term debt | 3,748 | 3,429 | 3,966 | 4,013 | 4,010 | ||||||
Liabilities to Banks | - | - | - | - | - | ||||||
Provisions | - | - | - | - | - | ||||||
Liabilities | 5,548 | 5,736 | 7,156 | 7,217 | 7,128 | ||||||
Share Capital | 2 | 2 | 2 | 2 | 2 | ||||||
Total Equity | 4,955 | 5,267 | 5,687 | 6,809 | 6,483 | ||||||
Minority Interests | 34 | 51 | 46 | 50 | 39 | ||||||
Total liabilities equity | 10,503 | 11,003 | 12,843 | 14,026 | 13,611 |
Income Statement
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 7,709 | 7,531 | 7,726 | 9,437 | 10,788 | ||||||
Depreciation (total) | 270 | 309 | 329 | 361 | 408 | ||||||
Operating Result | 1,165 | 1,101 | 1,231 | 1,971 | 2,381 | ||||||
Interest Income | -151 | -167 | -175 | -163 | -151 | ||||||
Income Before Taxes | 1,030 | 926 | 1,076 | 1,884 | 2,599 | ||||||
Income Taxes | -241 | -182 | -247 | -460 | -597 | ||||||
Minority Interests Profit | 52 | 52 | 48 | 68 | 85 | ||||||
Net Income | 772 | 736 | 858 | 1,431 | 1,995 |
Per Share
Cash Flow
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 1,175 | 1,200 | 1,243 | 2,005 | 2,233 | ||||||
Cash Flow from Investing Activities | -805 | -801 | -411 | -772 | 21 | ||||||
Cash Flow from Financing | -592 | -401 | 225 | -1,267 | -2,540 | ||||||
Decrease / Increase in Cash | -222 | -2 | 1,057 | -34 | -286 | ||||||
Employees | 45,000 | 46,000 | 47,000 | 49,000 | 49,000 |